Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (98)

2024

  1. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation

    Expert Review of Neurotherapeutics, Vol. 24, Núm. 9, pp. 913-928

  2. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842

  3. Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis

    European Journal of Clinical Investigation

  4. Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score

    European Journal of Internal Medicine

  5. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study

    Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1941-1948

2023

  1. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    American Journal of Cardiology, Vol. 203, pp. 122-127

  2. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  3. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

    Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662

  4. Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy

    Current Problems in Cardiology, Vol. 48, Núm. 10

  5. High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

    IJC Heart and Vasculature, Vol. 46

  6. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

  7. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Science of the Total Environment, Vol. 880

  8. Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

    IJC Heart and Vasculature, Vol. 46

  9. Impact of the COVID-19 pandemic on stress and sleep in emergency room professionals

    Journal of Clinical Nursing, Vol. 32, Núm. 15-16, pp. 5037-5045

  10. Incidence and predictors of sternal surgical wound infection in cardiac surgery: A prospective study

    International Wound Journal, Vol. 20, Núm. 4, pp. 917-924

  11. Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 2, pp. 602-610

  12. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

  13. Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment

    Medicina Clinica, Vol. 161, Núm. 8, pp. 344-350

  14. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

    Biomedicine and Pharmacotherapy, Vol. 158

  15. Progressions in Cardiac Arrhythmia: Specific Populations and the Need for Precision Medicine

    Journal of Personalized Medicine